Distinguished Prof Greg Peterson
BPharm(Hons), PhD, MBA, FSHP, FACP, FPS, GAICD, AACPA, ARPharmS
Director since 2018, elected second term to 2024
Greg has worked in the primary healthcare sector for over 30 years, and continues to split his time between the University of Tasmania, where he is distinguished professor of pharmacy, and a suburban pharmacy he co-owns. He brings to the Board extensive management, governance, health systems improvement and entrepreneurial expertise. Over many years, he has taught within medical, nursing, paramedicine and pharmacy courses, along with clinical redesign and health service improvement. Greg has 650 papers published in refereed international and national journals, plus research funding of over $47M as Chief Investigator. Greg is Chair of the Cancer Council Tasmania and Director of Cancer Council Australia and the Alcohol, Tobacco and other Drugs Council. He is a member of the Australian Government committee responsible for deciding which medicines should be listed on the Repatriation Pharmaceutical Benefits Scheme.